ID20291A - SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS - Google Patents

SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS

Info

Publication number: ID20291A
Authority: ID; Indonesia
Prior art keywords: oxycutiratic; metaloproteasa; matriers; acids; substituted
Prior art date: 1996-05-15

Application number

IDP971607A

Other languages

Indonesian (id)

Inventor

Brian R Dixon

Jinshan Chen

Michael Van Zandt

David R Brittelli

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-15

Filing date

1997-05-14

Publication date

1998-11-19

1997-05-14 Application filed by Bayer Ag filed Critical Bayer Ag

1998-11-19 Publication of ID20291A publication Critical patent/ID20291A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Peptides Or Proteins (AREA)

IDP971607A 1996-05-15 1997-05-14 SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS ID20291A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US64838496A	1996-05-15	1996-05-15

Publications (1)

Publication Number	Publication Date
ID20291A true ID20291A (en)	1998-11-19

Family

ID=24600568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP971607A ID20291A (en)	1996-05-15	1997-05-14	SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS

Country Status (18)

Country	Link
EP (1)	EP0912487A1 (en)
JP (1)	JP3417951B2 (en)
CN (1)	CN1163466C (en)
AR (1)	AR007096A1 (en)
AU (1)	AU727648B2 (en)
CA (1)	CA2253869C (en)
CO (1)	CO4990925A1 (en)
HR (1)	HRP970246B1 (en)
ID (1)	ID20291A (en)
MY (1)	MY132470A (en)
PA (1)	PA8429401A1 (en)
PE (1)	PE65998A1 (en)
SV (1)	SV1997000034A (en)
TN (1)	TNSN97085A1 (en)
TW (1)	TW467892B (en)
WO (1)	WO1997043238A1 (en)
YU (1)	YU18797A (en)
ZA (1)	ZA974032B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6288063B1 (en)	1998-05-27	2001-09-11	Bayer Corporation	Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
GB0321538D0 (en) *	2003-09-13	2003-10-15	Glaxo Group Ltd	Therapeutically useful compounds
WO2009022740A1 (en) *	2007-08-15	2009-02-19	Kyorin Pharmaceutical Co., Ltd.	Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient
EP3126358A1 (en)	2014-04-03	2017-02-08	Bayer Pharma Aktiengesellschaft	2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases
US20170022171A1 (en)	2014-04-03	2017-01-26	Bayer Pharma Aktiengesellschaft	2,5-disubstituted cyclopentanecarboxylic acids and their use
EP3126340A2 (en)	2014-04-03	2017-02-08	Bayer Pharma Aktiengesellschaft	Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0905126B1 (en) *	1994-01-22	2002-12-04	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors

1997
- 1997-05-09 HR HR970246A patent/HRP970246B1/en not_active IP Right Cessation
- 1997-05-09 ZA ZA9704032A patent/ZA974032B/en unknown
- 1997-05-09 MY MYPI97002045A patent/MY132470A/en unknown
- 1997-05-09 TN TNTNSN97085A patent/TNSN97085A1/en unknown
- 1997-05-09 CO CO97025164A patent/CO4990925A1/en unknown
- 1997-05-12 YU YU18797A patent/YU18797A/en unknown
- 1997-05-12 AR ARP970101976A patent/AR007096A1/en unknown
- 1997-05-12 JP JP54100297A patent/JP3417951B2/en not_active Expired - Fee Related
- 1997-05-12 CN CNB971964599A patent/CN1163466C/en not_active Expired - Fee Related
- 1997-05-12 TW TW086106284A patent/TW467892B/en not_active IP Right Cessation
- 1997-05-12 PA PA19978429401A patent/PA8429401A1/en unknown
- 1997-05-12 WO PCT/US1997/007975 patent/WO1997043238A1/en not_active Application Discontinuation
- 1997-05-12 AU AU31219/97A patent/AU727648B2/en not_active Ceased
- 1997-05-12 CA CA002253869A patent/CA2253869C/en not_active Expired - Fee Related
- 1997-05-12 PE PE1997000362A patent/PE65998A1/en not_active Application Discontinuation
- 1997-05-12 EP EP97926454A patent/EP0912487A1/en not_active Withdrawn
- 1997-05-12 SV SV1997000034A patent/SV1997000034A/en not_active Application Discontinuation
- 1997-05-14 ID IDP971607A patent/ID20291A/en unknown

Also Published As

Publication number	Publication date
ZA974032B (en)	1998-02-19
AU727648B2 (en)	2000-12-21
CO4990925A1 (en)	2000-12-26
PA8429401A1 (en)	2000-05-24
CN1225622A (en)	1999-08-11
CA2253869C (en)	2003-04-22
JPH11509870A (en)	1999-08-31
CA2253869A1 (en)	1997-11-20
WO1997043238A1 (en)	1997-11-20
CN1163466C (en)	2004-08-25
TNSN97085A1 (en)	2005-03-15
YU18797A (en)	1999-11-22
HRP970246A2 (en)	1998-04-30
EP0912487A1 (en)	1999-05-06
PE65998A1 (en)	1998-10-20
AR007096A1 (en)	1999-10-13
TW467892B (en)	2001-12-11
MY132470A (en)	2007-10-31
SV1997000034A (en)	1999-07-05
JP3417951B2 (en)	2003-06-16
AU3121997A (en)	1997-12-05
HRP970246B1 (en)	2002-04-30

Publication	Publication Date	Title
BR9510256A (en)	1997-11-04	Derivatives of 3-aryl-tetronic acid
ID16866A (en)	1997-11-20	COMPLEX COMPLEX OF ARYL-HETEROSICLIC SALT INCLUSION
DE69703385D1 (en)	2000-11-30	ALCOXYACETIC ACID DERIVATIVES
NO990821D0 (en)	1999-02-22	Arylsulfonylamino-hydroxamic acid derivatives
NO307961B1 (en)	2000-06-26	Method of Preparation of an Ester
EE200000573A (en)	2002-04-15	Substituted indolealkanoic acids
ID19227A (en)	1998-06-28	METHOD OF PRODUCING CARBOXIC ACIDS
DK0877018T3 (en)	2003-08-25	Sulfonylaminocarboxylic acids
EE04281B1 (en)	2004-04-15	Process for the preparation of 8-methoxyquinolone carboxylic acids
DE69804513D1 (en)	2002-05-02	PRODUCTION OF ZEOLITH-L
PT829205E (en)	2002-05-31	PRODUCTION OF CONDIMENTO
ATE230734T1 (en)	2003-01-15	3-ALKOXYISOXAZOLE-4-YL-SUBSTITUTED 2-AMINOCARBOXYLIC ACID DERIVATIVES
ID22222A (en)	1999-09-16	PROCESS OF MAKING SUBSTITUTED TIAZOLIDINADION
ID16838A (en)	1997-11-13	COMPOSITION OF DEKAFLUOROPENTANA
ID21901A (en)	1999-08-12	PROCESS OF MAKING HYDROXYLAMONIUM SALT
ATE222704T1 (en)	2002-09-15	PRODUCTION OF FROZEN CONFESSIONALS
ID18300A (en)	1998-03-26	METHOD OF PENEMPERAN
NO20001777L (en)	2000-05-03	Process for the preparation of substituted 4-phenyl-4-cyanocyclohexanecarboxylic acids
ID20291A (en)	1998-11-19	SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS
ID16364A (en)	1997-09-25	PROCESS OF MAKING MULTIDENTAT COMPOUND FOSFIT
DE69707251D1 (en)	2001-11-15	Maleimidobenzoic acid ester
ID17419A (en)	1997-12-24	COMPOSITION OF DEKAFLUOROPENTANA
ID19799A (en)	1998-08-06	PROCESS OF MAKING PAKLITAKSEL
NO980316D0 (en)	1998-01-23	Process for the preparation of N-vinylcarprolactam polymerisates
DE69707882D1 (en)	2001-12-06	CARBONYLATION PROCEDURE OF PENTENIC ACIDS